GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » EBITDA Margin %

CBD Life Sciences (CBD Life Sciences) EBITDA Margin % : 0.00% (As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CBD Life Sciences's EBITDA for the three months ended in Sep. 2015 was $-0.02 Mil. CBD Life Sciences's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, CBD Life Sciences's EBITDA margin for the quarter that ended in Sep. 2015 was 0.00%.


CBD Life Sciences EBITDA Margin % Historical Data

The historical data trend for CBD Life Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences EBITDA Margin % Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
EBITDA Margin %
- - -195.51 -603.25

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -18.70 - - -

Competitive Comparison of CBD Life Sciences's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CBD Life Sciences's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's EBITDA Margin % falls into.



CBD Life Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CBD Life Sciences's EBITDA Margin % for the fiscal year that ended in Dec. 2014 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-0.742/0.123
=-603.25 %

CBD Life Sciences's EBITDA Margin % for the quarter that ended in Sep. 2015 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=-0.018/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CBD Life Sciences  (OTCPK:CBDL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CBD Life Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.